TCL Archive IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover July 25, 2014
TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014